Etoloxamine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NEZ417265P. European Medicines Agency schedules Etoloxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07329MIG. Etoloxamine generally arises in the molecular formula C19H25NO. The term ETOLOXAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, no. 10 1973, list 13.) ETOLOXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etoloxamine under HS 29221980 and SITC 51461. As of Q4 2014, ETOLOXAMINE remains the US FDA Preferred Term for this commodity. Etoloxamine bears US NLM identifiers UMLS ID C0659884 and NCI Concept Code C65594. SMILES: O(CCN(CC)CC)C1C(CC2CCCCC2)CCCC1.